PubMed Health⌕ Search
Home/Archive/PubMed

PubMed · 15997509

Some new problems in biomedical regulation.

N Tonti-Filippini
View original source ↗Export metadata ↓

Abstract

The purpose of this paper is to present rather than resolve some new ethical problems which are likely to become the subject of public discussion in the near future. Some problems likely to be the subjects of extensive debate are: the foetal patient, 'home abortifacients' and abortifacient vaccines, the withdrawal of life-sustaining treatment, experimentation on 'spare' human embryos, the legalization of heroin abuse and the use of anencephalics and the persistently comatose as organ donors.

Explore related subjects

Abortifacient AgentsAnencephalyAustraliaBioethical IssuesCatholicismEmbryo ResearchEuthanasia, PassiveFemaleHeroin DependenceHumansMifepristonePregnancyPregnant PeopleTissue and Organ ProcurementTreatment RefusalVaccines, ContraceptiveBioethics and Professional EthicsLegal ApproachJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

N Tonti-Filippini. 1990. Some new problems in biomedical regulation.. https://pubmed.ncbi.nlm.nih.gov/15997509/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Mid-trimester induced abortion: a review.

Mid-trimester abortion constitutes 10-15% of all induced abortion. The aim of this article is to provide a review of the current literature of mid-trimester methods of abortion with respect to efficacy, side effects and acceptability. There have been continuing efforts to improve the abortion technology in terms of effectiveness, technical ease of performance, acceptability and reduction of side effects and complications. During the last decade, medical methods for mid-trimester induced abortion have shown a considerable development and have become safe and more accessible. The combination of mifepristone and misoprostol is now an established and highly effective method for termination of pregnancy (TOP). Advantages and disadvantages of medical versus surgical methods are discussed. Randomized studies are lacking, and more studies on pain treatment and the safety of any method used in patients with a previous uterine scar are debated, and data are scarce. Pain management in abortion requires special attention. This review highlights the need for randomized studies to set guidelines for mid-trimester abortion methods in terms of safety and acceptability as well as for better analgesic regimens.

Abortifacient Agents↗
PubMed2006

Silent rupture of unscarred uterus: an unusual presentation at second trimester abortion.

Rupture of unscarred uterus during the second trimester is rare. A case of ruptured uterus in a multiparous woman is presented. To our knowledge, this might be the first reported case in the English literature of uterine rupture during second trimester termination of pregnancy using ethacridine lactate. This case is also rare as uterine rupture is presented with an insidious course rather than acute, thus delaying the diagnosis.

Abortifacient Agents↗